{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:59:16Z","timestamp":1792094356528,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IB201812"],"award-info":[{"award-number":["IB201812"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011042","name":"Instituto Cient\u00edfico Pfizer","doi-asserted-by":"publisher","award":["IB201812"],"award-info":[{"award-number":["IB201812"]}],"id":[{"id":"10.13039\/100011042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.nrleng.2018.10.022","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T13:40:00Z","timestamp":1613396400000},"page":"110-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson\u2019s diseases"],"prefix":"10.1016","volume":"37","author":[{"given":"S.","family":"Garfias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Tamaya Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Toledo Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Boll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sciutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Adalid-Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Martinez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2018.10.022_bib0005","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2018.10.022_bib0010","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrn3039","article-title":"Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates","volume":"12","author":"Collier","year":"2011","journal-title":"Nat Rev Neurosci."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fncel.2015.00124","article-title":"Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases","volume":"9","author":"Chin-Chan","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0025","first-page":"309","article-title":"Genetics of neurodegenerative diseases: an overview","volume":"145","author":"Pihlstr\u00f8m","year":"2017","journal-title":"Handb Clin Neurol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0035","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0040","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ana.22487","article-title":"Stem Cell Technology for Neurodegenerative Diseases","volume":"70","author":"Simon Lunn","year":"2011","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","article-title":"Epidemiology of Alzheimer disease","volume":"7","author":"Reitz","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.arr.2013.12.009","article-title":"Are dopamine derivatives implicated in the pathogenesis of Parkinson\u2019s disease?","volume":"13","author":"Bisaglia","year":"2014","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0060","doi-asserted-by":"crossref","first-page":"624925","DOI":"10.1155\/2012\/624925","article-title":"Oxidative stress in genetic mouse models of Parkinson\u00b4s disease","volume":"2012","author":"Varcin","year":"2012","journal-title":"Oxid Med Cell Longev."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0065","doi-asserted-by":"crossref","first-page":"628192","DOI":"10.1155\/2015\/628192","article-title":"Insights into Neuroinflammation in Parkinson\u2019s Disease: From Biomarkers to Anti-Inflammatory Based Therapies","volume":"2015","author":"Rocha","year":"2015","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0070","doi-asserted-by":"crossref","first-page":"4626540","DOI":"10.1155\/2017\/4626540","article-title":"T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer\u2019s Disease: Potential Pools of New Biomarkers","volume":"2017","author":"Mietelska-Porowska","year":"2017","journal-title":"J Immunol Res."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0075","first-page":"13","article-title":"CD4+ T cells mediate cytotoxicity in neurodegenerative diseases","volume":"119","author":"Appel","year":"2009","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jns.2017.03.031","article-title":"Role of inflammatory molecules in the Alzheimer\u2019s disease progression and diagnosis","volume":"376","author":"Bagyinszky","year":"2017","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0085","doi-asserted-by":"crossref","first-page":"169203","DOI":"10.1155\/2014\/169203","article-title":"Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly","volume":"2014","author":"Arosio","year":"2014","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0090","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1586\/ern.09.118","article-title":"Can peripheral leukocytes be used as Alzheimer\u2019s disease biomarkers?","volume":"9","author":"Rezai-Zadeh","year":"2009","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0095","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/acschemneuro.6b00042","article-title":"The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and Huntington\u2019s Disease","volume":"7","author":"Clark","year":"2016","journal-title":"ACS Chem Neurosci."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1567205013666151116124912","article-title":"Lymphocytes in Alzheimer\u2019s disease pathology: Altered signaling pathways","volume":"13","author":"Esteras","year":"2016","journal-title":"Curr Alzheimer Res."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychires.2006.01.010","article-title":"Altered lymphocyte distribution in Alzheimer\u2019s disease","volume":"41","author":"Richartz-Salzburger","year":"2007","journal-title":"J Psychiatr Res."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0110","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.neurobiolaging.2006.05.020","article-title":"Lymphocyte subset patterns and cytokine production in Alzheimer\u2019s disease patients","volume":"28","author":"Speciale","year":"2007","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2014.08.008","article-title":"Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer\u2019s disease","volume":"36","author":"Lueg","year":"2015","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2009-1015","article-title":"Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer\u2019s disease","volume":"17","author":"Larbi","year":"2009","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ Regulatory and Effector\/Memory T Cell Subsets Profile Motor dysfunction in Parkinson\u2019s Disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J Neuroimmune Pharmacol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0130","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.3892\/mmr.2015.4136","article-title":"Clinical correlation of peripheral CD4+\u2011cell sub\u2011sets, their imbalance and Parkinson\u2019s disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS- ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKahnn","year":"1984","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: Status and Recommendations. The Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0150","first-page":"31","article-title":"Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease","volume":"10","author":"Clark","year":"1996","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","article-title":"Immunologic privilege in the central nervous system and the blood-brain barrier","volume":"33","author":"Muldoon","year":"2013","journal-title":"J Cereb Blood Flow Metab."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0160","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.coph.2008.07.009","article-title":"Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation","volume":"8","author":"Fabry","year":"2008","journal-title":"Curr Opin Pharmacol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-017-0241-2","article-title":"Role of neuroinflammation in neurodegeneration: new insights","volume":"9","author":"McManus","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.02.002","article-title":"The role of exosomes in CNS inflammation and their involvement in multiple sclerosis","volume":"306","author":"Selmaj","year":"2017","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0175","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0180","doi-asserted-by":"crossref","first-page":"952375","DOI":"10.1155\/2013\/952375","article-title":"Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"2013","author":"More","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2009.12.017","article-title":"Apoptosis of peripheral blood lymphocytes in Parkinson patients","volume":"38","author":"Calopa","year":"2010","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2014.08.002","article-title":"Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation","volume":"54","author":"Schwartz","year":"2014","journal-title":"J Autoimmun."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0195","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","article-title":"CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production","volume":"188","author":"Thornton","year":"1998","journal-title":"J Exp Med."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0200","article-title":"The role of regulatory T cells in nervous system pathologies","author":"Duffy","year":"2017","journal-title":"J Neurosci Res."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0205","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/brain\/awv408","article-title":"Regulatory T cells delay disease progression in Alzheimer-like pathology","volume":"139","author":"Dansokho","year":"2016","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0215","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J Immunol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","article-title":"Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?","volume":"4","author":"Lan","year":"2012","journal-title":"J Mol Cell Biol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-065X.2012.01130.x","article-title":"Regulatory T cells in the central nervous system","volume":"248","author":"Lowther","year":"2012","journal-title":"Immunol Rev."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0230","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer\u2019s disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat Commun."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1189\/jlb.3A0414-213RR","article-title":"Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis","volume":"97","author":"Xing","year":"2015","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol."},{"key":"10.1016\/j.nrleng.2018.10.022_bib0245","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2174\/1567205010666131212113218","article-title":"Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-\u03b2 ex vivo activation of peripheral chemo-cytokines from Alzheimer\u2019s disease subjects: exploring the cholinergic anti-inflammatory pathway","volume":"11","author":"Reale","year":"2014","journal-title":"Curr Alzheimer Res."}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580821000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580821000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:33:52Z","timestamp":1761881632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580821000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2173580821000109"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2018.10.022","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson\u2019s diseases","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2018.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2018.10.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}